Macrophage IFN-I signaling promotes autoreactive T cell infiltration into islets in type 1 diabetes model.
Autoimmunity
Cytokines
Diabetes
Immunology
Macrophages
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
24 Jan 2019
24 Jan 2019
Historique:
received:
24
09
2018
accepted:
11
12
2018
pubmed:
25
1
2019
medline:
25
1
2019
entrez:
25
1
2019
Statut:
epublish
Résumé
Here, we report a pathogenic role for type I IFN (IFN-I) signaling in macrophages, and not β cells in the islets, for the development of type 1 diabetes (T1D). Following lymphocytic choriomeningitis (LCMV) infection in the Rip-LCMV-GP T1D model, macrophages accumulated near islets and in close contact to islet-infiltrating GP-specific (autoimmune) CD8+ T cells. Depletion of macrophages with clodronate liposomes or genetic ablation of Ifnar in macrophages aborted T1D, despite proliferation of GP-specific (autoimmune) CD8+ T cells. Histopathologically, disrupted IFNα/β receptor (IFNAR) signaling in macrophages resulted in restriction of CD8+ T cells entering into the islets with significant lymphoid accumulation around the islet. Collectively, these results provide evidence that macrophages via IFN-I signaling, while not entering the islets, are directly involved in interacting, directing, or restricting trafficking of autoreactive-specific T cells into the islets as an important component in causing T1D.
Identifiants
pubmed: 30674713
pii: 125067
doi: 10.1172/jci.insight.125067
pmc: PMC6413832
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI099699
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007244
Pays : United States